Targeting USP42 induces DNA damage and inhibits cell growth in prostate cancer
BackgroundProstate cancer (PCa) is one of the most common cancers in men worldwide. During its progression, deubiquitination-mediated alterations in biological processes play critical roles in tumor metabolism, stem cell characteristics, immune evasion, DNA damage repair, and chemoresistance. A comp...
Saved in:
| Main Authors: | Yinghao Zhou, Chenchen Chen, Yibo Meng, Jianchao Ge, Shengkui Meng, Xillong Wang, Yaozong Xu, Guowei Shi, Wandong Yu, Xuetao Hu, Jun Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Molecular Biosciences |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2025.1646331/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Olaparib induced aplastic anemia in a patient with castrate resistant prostate cancer: A case report
by: Elrazi A Ali, et al.
Published: (2024-01-01) -
Androgen receptor inhibitors in treating prostate cancer
by: Ryan N Cole, et al.
Published: (2025-03-01) -
Immunohistochemical expression of androgen receptors in prostate carcinoma and benign prostatic hyperplasia
by: Trivunić-Dajko Sandra, et al.
Published: (2020-01-01) -
Divergent androgen regulation of unfolded protein response pathways drives prostate cancer
by: Xia Sheng, et al.
Published: (2015-04-01) -
The role of the androgen receptor in prostate development and benign prostatic hyperplasia: A review
by: Renee E. Vickman, et al.
Published: (2020-07-01)